Concepedia

Daniela Sambataro

DS

Statistics

Publications

11

Citations

650

H-Index

10

Active since

1993

Affiliations

Istituti di Ricovero e Cura a Carattere Scientifico(Current)

University of Catania

Ospedale Garibaldi

Ospedale A. Perrino

Ospedale Infermi di Rimini

Daniela Sambataro is an author at Istituti di Ricovero e Cura a Carattere Scientifico specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

1993–2023

11

Publications

11

Pazopanib plus weekly paclitaxel versus weekly paclitaxel alone for platinum-resistant or platinum-refractory advanced ovarian cancer (MITO 11): a randomised, open-label, phase 2 trial

Sandro Pignata, Domenica Lorusso, Giovanni Scambia et al. · The Lancet Oncology · 2015 · 170 citations · Full text

, , +8

Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer: a randomised, phase 3 trial

Sandro Pignata, Domenica Lorusso, Florence Joly et al. · The Lancet Oncology · 2021 · 144 citations

, , +7

Single agent 2',2'-difluorodeoxycytidine in the treatment of metastatic urothelial carcinoma: a phase II study.

Vittorio Gebbia, A. C. Testa, Nicola Borsellino et al. · PubMed · 1999 · 68 citations

Prognostic Factors for Adrenocortical Carcinoma Outcomes

Claudia Scollo, Marco Russo, Maria Antonietta Trovato et al. · Frontiers in Endocrinology · 2016 · 50 citations · Full text

A combined hepatocellular/cholangiocellular carcinoma with sarcomatoid features

Mauro Papotti, Daniela Sambataro, P. Marchesa et al. · Liver International · 1997 · 49 citations

1–5 of 11